We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$13.3B
AUM Growth
+$1.76B
Cap. Flow
+$887M
Cap. Flow %
6.65%
Top 10 Hldgs %
15.56%
Holding
2,105
New
197
Increased
1,128
Reduced
591
Closed
147

Sector Composition

Rank Sector Weight
1 Energy 9.36%
2 Healthcare 7.85%
3 Industrials 7.72%
4 Technology 7.64%
5 Financials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OHAI
901
DELISTED
OHA Investment Corporation
OHAI
$2.21M 0.02%
295,442
+6,217
+2% +$47.1K
CSQ icon
902
Calamos Strategic Total Return Fund
CSQ
$3.35B
$2.21M 0.02%
202,588
+31,763
+19% +$334K
DFT
903
DELISTED
DuPont Fabros Technology Inc.
DFT
$2.2M 0.02%
89,045
+6,465
+8% +$157K
PSA icon
904
Public Storage
PSA
$61.3B
$2.2M 0.02%
14,596
+1,587
+12% +$254K
OI icon
905
O-I Glass
OI
$1.08B
$2.19M 0.02%
61,197
+8,739
+17% +$282K
JQC icon
906
Nuveen Credit Strategies Income Fund
JQC
$711M
$2.19M 0.02%
224,631
-39,366
-15% -$370K
OC icon
907
Owens Corning
OC
$12.4B
$2.19M 0.02%
+53,660
New +$2.04M
SEMG
908
DELISTED
SEMGROUP CORPORATION
SEMG
$2.18M 0.02%
+33,410
New +$2.01M
FL
909
DELISTED
Foot Locker
FL
$2.17M 0.02%
52,342
-8,922
-15% -$327K
CVRR
910
DELISTED
CVR Refining, LP
CVRR
$2.17M 0.02%
95,909
-8,971
-9% -$207K
DOX icon
911
Amdocs
DOX
$6.22B
$2.16M 0.02%
52,443
+9,460
+22% +$372K
NEM icon
912
Newmont
NEM
$119B
$2.16M 0.02%
93,898
-78,218
-45% -$2.01M
RMD icon
913
ResMed
RMD
$30.7B
$2.16M 0.02%
45,925
-6,289
-12% -$318K
CAPL icon
914
CrossAmerica Partners
CAPL
$817M
$2.16M 0.02%
75,575
+24,609
+48% +$688K
RGA icon
915
Reinsurance Group of America
RGA
$16.1B
$2.16M 0.02%
27,916
-3,184
-10% -$232K
UTX.PRA
916
DELISTED
UNITED TECHNOLOGIES CORP CORP UNIT (DE)
UTX.PRA
$2.16M 0.02%
32,971
-2,117
-6% -$136K
DBEF icon
917
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.39B
$2.15M 0.02%
+78,511
New +$2.08M
AVT icon
918
Avnet
AVT
$7.92B
$2.15M 0.02%
48,791
+2,164
+5% +$89.3K
MLCO icon
919
Melco Resorts & Entertainment
MLCO
$2.14B
$2.14M 0.02%
54,466
+8,484
+18% +$300K
PLD icon
920
Prologis
PLD
$133B
$2.14M 0.02%
57,807
+3,234
+6% +$124K
GNW icon
921
Genworth Financial
GNW
$3.71B
$2.13M 0.02%
137,505
+86,661
+170% +$1.25M
MCF
922
DELISTED
Contango Oil & Gas Co.
MCF
$2.12M 0.02%
44,915
+409
+0.9% +$18K
RFMD
923
DELISTED
RF MICRO DEVICES INC
RFMD
$2.12M 0.02%
411,152
+237,933
+137% +$1.28M
ATCO
924
DELISTED
Atlas Corp.
ATCO
$2.12M 0.02%
92,365
+75,384
+444% +$1.68M
DLTR icon
925
Dollar Tree
DLTR
$25.2B
$2.12M 0.02%
37,549
+3,276
+10% +$189K

Similar funds

Raymond James & Associates's Q4 2013 Portfolio in Review

As of Q4 2013, Raymond James & Associates held 2,105 positions worth $13.3B, up 15% from $11.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Raymond James & Associates deployed $887M of net new capital in Q4 2013, opening 197 new positions and adding to 1,128 existing holdings. Its largest new stake was Antero Resources: 107,136 shares worth $6.8M.

By sector, the portfolio is most concentrated in Energy at 9.4% of assets, down from 9.4% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $12.7M trimmed.

  • Raymond James & Associates's largest Q4 2013 buy was Antero Resources: 107,136 shares worth $6.8M.
  • Raymond James & Associates added most to iShares Russell 1000 Growth ETF in Q4 2013, an estimated $30M increase.
  • Raymond James & Associates's biggest Q4 2013 reduction was Walgreens Boots Alliance, cutting an estimated $12.7M.
  • Raymond James & Associates fully exited Chipotle Mexican Grill in Q4 2013, selling an estimated $4.75M.
  • Raymond James & Associates's ten largest holdings make up 16% of its $13.3B portfolio in Q4 2013.
  • Raymond James & Associates opened 197 new positions and closed 147 in Q4 2013.
  • Raymond James & Associates's portfolio value rose 15% quarter-over-quarter to $13.3B.

Based on Raymond James & Associates's 13F filing for Q4 2013, filed 13 Feb 2014.